U.S. approves Glaxo's cervical cancer vaccine (Reuters)

Sexual Health - Y! Health Sexual Health & STDs News - 2009, October 16, 7:32 PM

Reuters - GlaxoSmithKline PLC won U.S. approval on Friday to sell a long-delayed vaccine against the virus that causes cervical cancer.

Read more | Previous | Next